Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon J Metge

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Oncoimmunology|February 7, 2019
Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancerAnn Hanna, Brandon J Metge, Sarah K Bailey, et al.
Clinical & Experimental Metastasis|June 21, 2008
Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancerBrandon J Metge, Andra R Frost, Judy A King, et al.
Cell Death Discovery|July 9, 2026
Merlin deficiency supports an immunosuppressive milieu in breast cancerMohamed H Elbahoty, Brandon J Metge, Amr R Elhamamsy, et al.
The Journal of Biological Chemistry|October 4, 2011
Loss of tumor suppressor Merlin in advanced breast cancer is due to post-translational regulationK Adam Morrow, Shamik Das, Brandon J Metge, et al.
Oncogene|January 13, 2018
Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumorsHawley C Pruitt, Brandon J Metge, Shannon E Weeks, et al.
Nucleic Acids Research|September 7, 2020
Hedgehog signaling enables repair of ribosomal DNA double-strand breaksTshering D Lama-Sherpa, Victor T G Lin, Brandon J Metge, et al.
Cancer Research|February 4, 2025
Ribosomal RNA Biosynthesis Functionally Programs Tumor-Associated Macrophages to Support Breast Cancer ProgressionBrandon J Metge, Li'an Williams, Courtney A Swain, et al.
Oncogenesis|June 3, 2021
Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumorsHeba Allah M Alsheikh, Brandon J Metge, Hawley C Pruitt, et al.
Cell Death and Differentiation|January 8, 2026
TRMT112 drives a tumor growth and metastasis-promoting program in triple-negative breast cancerAmr R Elhamamsy, Brandon J Metge, Mohamed H Elbahoty, et al.
Clinical & Experimental Metastasis|July 11, 2006
Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435Lalita A Shevde, Rajeev S Samant, Jason C Paik, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Oncoimmunology|February 7, 2019
Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancerAnn Hanna, Brandon J Metge, Sarah K Bailey, et al.
Clinical & Experimental Metastasis|June 21, 2008
Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancerBrandon J Metge, Andra R Frost, Judy A King, et al.
Cell Death Discovery|July 9, 2026
Merlin deficiency supports an immunosuppressive milieu in breast cancerMohamed H Elbahoty, Brandon J Metge, Amr R Elhamamsy, et al.
The Journal of Biological Chemistry|October 4, 2011
Loss of tumor suppressor Merlin in advanced breast cancer is due to post-translational regulationK Adam Morrow, Shamik Das, Brandon J Metge, et al.
Oncogene|January 13, 2018
Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumorsHawley C Pruitt, Brandon J Metge, Shannon E Weeks, et al.
Nucleic Acids Research|September 7, 2020
Hedgehog signaling enables repair of ribosomal DNA double-strand breaksTshering D Lama-Sherpa, Victor T G Lin, Brandon J Metge, et al.
Cancer Research|February 4, 2025
Ribosomal RNA Biosynthesis Functionally Programs Tumor-Associated Macrophages to Support Breast Cancer ProgressionBrandon J Metge, Li'an Williams, Courtney A Swain, et al.
Oncogenesis|June 3, 2021
Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumorsHeba Allah M Alsheikh, Brandon J Metge, Hawley C Pruitt, et al.
Cell Death and Differentiation|January 8, 2026
TRMT112 drives a tumor growth and metastasis-promoting program in triple-negative breast cancerAmr R Elhamamsy, Brandon J Metge, Mohamed H Elbahoty, et al.
Clinical & Experimental Metastasis|July 11, 2006
Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435Lalita A Shevde, Rajeev S Samant, Jason C Paik, et al.
Pageof 4